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Abstract
Background: Antibodies are often involved in enhancing particle clearance by macrophages. Although the mechanisms of
antibody-dependent phagocytosis have been studied for IgG in greater detail, very little is known about IgM-mediated
clearance. It has been generally considered that IgM does not support phagocytosis. Recent studies indicate that natural
IgM is important to clear microbes and other bioparticles, and that shape is critical to particle uptake by macrophages;
however, the relevance of IgM and particle size in their clearance remains unclear. Here we show that IgM has a size-
dependent effect on clearance.
Methodology/Principal Findings: We used antibody-opsonized sheep red blood cells, different size beads and apoptotic
cells to determine the effect of human and mouse IgM on phagocytosis by mouse alveolar macrophages. Our microscopy
(light, epifluorescence, confocal) and flow cytometry data show that IgM greatly enhances the clearance of small particles
(about 1–2 micron) by these macrophages. There is an inverse relationship between IgM-mediated clearance by
macrophages and the particle size; however, macrophages bind and internalize many different size particles coated with
IgG. We also show that IgM avidly binds to small size late apoptotic cells or bodies (2–5 micron) and apoptotic
microparticles (,2 mm) released from dying cells. IgM also promotes the binding and uptake of microparticle-coated beads.
Conclusions/Significance: Therefore, while the shape of the particles is important for non-opsonized particle uptake, the
particle size matters for antibody-mediated clearance by macrophages. IgM particularly promotes the clearance of small size
particles. This finding may have wider implications in IgM-mediated clearing of antigens, microbial pathogens and dying
cells by the host.
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Introduction
Particle clearance is an essential function performed by
phagocytes such as macrophages [1]. Antibodies and other soluble
innate immune proteins are often involved in opsonizing and
promoting the clearance of biological material by macrophages
[1,2,3]. It is very well established that IgG-coated particles are
engulfed efficiently by macrophages [4,5]; yet, little is known about
the role of IgM in particle clearance. Recent studies indicate that
shape, but not the size, is critical to the uptake of particles by
macrophages [6]. However, the importance of size in antibody-
opsonized particle clearance has not been clearly established. The
aim of this study is to determine the importance of particle size in
IgM-opsonized particle clearance.
Recent studies highlight the importance of natural IgM in
opsonizing microbes [7,8,9,10,11,12] and dying immune cells for
clearance by phagocytes [13,14,15,16]. In this context, natural
IgM is considered as an innate immune protein that recognizes
non-self particles [14,17]. Many recent studies also indicate that
natural IgM can recognize damaged-self such as late apoptotic or
necrotic cells in various tissues [14,18,19,20,21]. Most of these
studies focused on understanding the role of complement
activation on IgM-mediated late apoptotic cell clearance
[13,18,20,21,22,23,24,25]. Other in vivo studies show that IgM
can protect immune complex-mediated damage in specific tissues
[26,27]. Notably, similar to secretory IgA, IgM can reach mucosal
surfaces independently of other complement proteins by Th17
regulated transcytosis [9,28,29]. The conundrum is that IgG [4,5],
but not IgM, is considered to mediate phagocytosis. This
paradigm led large number of studies to focus on determining
the role of IgG, but not of IgM, for phagocytosis.
Our previous studies show that IgM enhances the clearance of
late apoptotic cells by macrophages in the absence of any
complement activating conditions such as lung inflammation, in
vivo [30]. We found that IgM interacts with a population of late
apoptotic cells (.,5 mm) in specific locations (punctate pattern)
[30]. In this study, we focus on the role of IgM on small size-late
apoptotic cells and blebs/microparticles. Apoptotic cells are
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IgM-mediated clearance of these particles by macrophages has not
been studied in detail. Understanding the importance of the
clearance of small bioparticles and various types of microparticles
in many diseases has gained great interest in the recent years
[32,33,34]. We hypothesized that IgM mediates the clearance of
small particles by macrophages. We have tested this hypothesis
using sheep red blood cells (sRBC), various size beads and late
apoptotic blebs and microparticles. This study establishes that IgM
enhances the clearance of small particle uptake by macrophages.
We propose that IgM-opsonized small particle clearance is an
alternative pathway to bypass the need for complement activating
inflammation-exacerbating pathway that causes excessive tissue
damage. Hence, our findings could have a broader biological
relevance.
Results
IgG, but not IgM, efficiently enhances the uptake of red
blood cells by macrophages
To evaluate the ability of IgM to regulate the uptake of
biological material, we used sRBCs as a model biological particle
(,7–10 mm) for phagocytosis [35]. We coated sRBCs with anti-
sRBC IgG or IgM and incubated them with freshly isolated mouse
macrophages for 30 minutes. These macrophages readily engulfed
IgG-coated sRBCs, displaying a phagocytic index 20-fold greater
(4263) than that of the negative control (2.260.2; p,0.05; Fig. 1).
IgM-mediated phagocytosis of sRBCs shows a peak at 1/200
antibody dilution (8.461); however, considering all the conditions,
IgM coating of sRBCs did not show significant phagocytosis of
sRBCs by macrophages. Hence, IgG, but not IgM, can greatly
facilitate the phagocytosis of these large bioparticles by macro-
phages.
IgG, but not IgM, efficiently enhances the binding and
uptake of large beads by macrophages
After identifying that IgM is not effective in directing
macrophage engulfment of sRBCs, we tested similar sized beads
as a model particle to eliminate the influence of any potential
ligands present on the sRBCs that may inhibit IgM-mediated
uptake. We compared the uptake by macrophages of large
(8.31 mm) beads coated with IgM, IgG, BSA or PBS. Beads were
fed to the macrophages for 30 minutes, and attached or
internalized beads were assessed by DIC microscopy (Fig. 2A).
We found that beads coated with 100 mg/ml or 500 mg/ml of IgG
and fed to macrophages were readily bound or phagocytosed by
73.4% or 80.1% of the macrophages, respectively (p,0.05). Bead
uptake saturates at 100–500 mg/ml IgG concentrations; hence we
used similar concentration range for IgM. However, beads coated
with 100 or 500 mg/ml IgM were bound or taken in only by less
than 8.7% of macrophages. We further assessed the frequency of
macrophages containing multiple beads and categorized the
macrophages as a function of ‘beads/cell’ (Fig. 2B). Only the
macrophages receiving beads coated with IgG displayed notable
frequencies of ‘beads/cell’ exceeding 1 bead/cell (Figs. 2B, C).
Both the BSA and PBS control coating conditions did not promote
the binding or uptake of beads by macrophages (0 to 1.3%). These
data suggest that IgG, but not IgM, has the capacity to efficiently
promote macrophage uptake or clearance of large-sized beads or
particles.
IgM preferentially promotes the uptake of smaller
particles, whereas IgG enhances the uptake of small and
large particles by macrophages
We compared a range of bead sizes to determine if IgM could
exert phagocytic functions on smaller particles. We tested four
sized beads with mean diameters of 1.58 mm, 3.87 mm, 5.19 mm
and 8.31 mm. Macrophages were incubated with the protein-
coated beads for 30 minutes. These cells were scored for bead
binding and uptake as a function of particle size and protein
condition (Fig. 3A). This analysis revealed that IgG effectively
directs macrophage binding and uptake of both small and large
particles. Small particles (1.58 mm beads) coated with IgG are
bound or taken up by 61.1% of macrophages, while this is even
greater, at 78.1% when the IgG-coated particles are larger
(8.31 mm). IgG shows a positive trend in promoting the clearance
of larger particles (Fig. 3A). It is interesting to note that IgM
however favours the clearance of the small particles. Small
(1.58 mm beads) and large (8.31 mm) particles coated with IgM are
bound or taken up by 38.3% and 9.69% of the macrophages,
respectively. Non-linear regression analyses show the relationship
between these two parameters (IgG: y=60.1 x
0.1354;r
2=.49; IgM:
y=51.624 x
20.815;r
2=0.94); their slopes have non-zero values
and these two regression lines are different from each other
(p,0.05). Therefore, these data confirm that IgM-mediated
binding and uptake is inversely related to particle size.
We further assessed the bead binding and uptake per cell
amongst each protein condition for each of the four bead sizes.
Macrophages that contained 1.58 mm beads coated with IgM
showed a notable frequency of cells involved in multiple bead
binding and uptake (Fig. 3B); whereas a similar analysis for larger
beads 3.87 mm (Fig. 3C), 5.19 mm (Fig. 1D), and 8.31 mm (Fig. 3E)
indicated a very low frequency of macrophages involved in
multiple IgM-coated bead binding and uptake. Conversely, beads
Figure 1. IgG, but not IgM, drastically enhances the uptake of
sRBCs by macrophages. Light microscopy analyses show that
macrophages effectively phagocytose IgG-coated sRBCs (,7–10 mm)
compared to control sRBC with no coating antibody (p,0.05). IgM-
coated sRBCs are not effectively taken up by the macrophages.
Although IgM coating conditions shows a small dose-dependence at
low concentrations of the antibody, this effect is less likely to represent
a biologically significant effect. Phagocytic index represents the number
of sRBCs internalized by 100 macrophages. Antibody dilutions used for
coating sRBCs are shown within parenthesis. Data are representative of
3 experiments performed on different days with similar results. Error
bars are 6 SEM from 3 technical replicates.
doi:10.1371/journal.pone.0017223.g001
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the bead size range (Fig. 3B–E). Macrophages incubated with
PBS-coated beads did not show notable levels of multiple bead
binding and internalization. Taken together these data suggest
that IgG directs the uptake by macrophages of a range of particle
sizes from small to large, but IgM preferentially directs
macrophage uptake of small particles only.
IgM enhances the clearance of small particles in a
concentration dependent manner
Following our finding that IgM preferentially enhances the
clearance of small particles by macrophages, we sought to
determine whether IgM promotes the clearance of beads in a
dose-dependent manner. We used fluorescent beads 1 micron in
diameter, coated the beads with varying concentrations of IgM
(0, 10, 100, 200 and 400 mg/ml) and incubated the beads with
macrophages for 30 minutes. Epifluorescence microscopy anal-
yses showed that compared to negative controls (PBS, BSA) both
IgM and IgG (100 mg/ml) influenced the pattern of uptake of the
beads by macrophages (Fig. 4A). Cells incubated with IgM- or
IgG-coated beads displayed dense irregular fluorescent masses
well within the perimeters of the cells, whereas cells incubated
with BSA or PBS alone displayed fluorescent beads mostly near
the perimeter of the cells. They exhibited mostly single point
fluorescence around the cells (Fig. 4A). Microscopy images
further show that coating the beads with increasing amounts of
IgM increased the degree of fluorescence detected in the
macrophages.
To verify that the intact antibodies are necessary for bead
uptake, 100 mg/ml IgG and IgM were treated with DTT, boiled
and coated onto the beads. These beads were washed and
incubated with macrophages; however, macrophages, did not take
up these beads to any significant degree (Fig. 4A). These results
show that intact IgG and IgM are necessary for promoting the
phagocytosis. To further show that mouse antibodies behave
similar to human antibodies (Fig. 4A), we repeated the bead
uptake experiments using mouse IgG, mouse IgM and mouse
macrophages. Both mouse IgG and IgM promoted the uptake of
small beads by mouse macrophages (Fig. 4B). Therefore, we
conclude that both human and mouse antibodies have similar
properties in promoting bead uptake by mouse macrophages.
Although epifluorescence microscopy is routinely used for bead
uptake experiments whether beads are internalized by the
macrophages cannot be precisely established by this procedure.
Therefore, we used confocal microscopy to determine the nature
of bead uptake by macrophages. Confocal analyses showed the
presence of large numbers of densely populated beads within the
macrophages when IgG- or IgM-coated beads were used, whereas
control BSA- and PBS-coated beads remained sparsely populated
within the cells (Fig. 5). Overall, these data suggest that the protein
coating of the beads by IgM and IgG directs internalization of
these small particles by macrophages.
Counting all the beads present in clusters within the cells is not
precise when smaller beads (e.g., 1 mm) are used; hence, to
quantify the IgM-mediated effort on small bead clearance we
repeated representative fluorescence microscopy experiments and
analyzed the macrophages using flow cytometry (Fig. 6). We
found that coating beads with IgM caused a concentration-
dependent increase in bead binding and uptake by macrophages
compared to negative control beads coated with either BSA
(100 mg/ml) or PBS only (Fig. 6A). Macrophages bound and
phagocytosed IgG-coated beads, as was expected from our
fluorescence microscopy experiments outlined above; however, to
more clearly understand the effect of IgM on the bead uptake, we
Figure 2. Human IgG, but not IgM, drastically enhances uptake of large beads by macrophages. (A) Macrophages effectively bind and
internalize IgG-coated, but not IgM-, BSA-, or PBS-coated, large beads (,8.31 mm; p,0.05). (B) Counting numbers of ‘‘beads/cell’’ shows that IgG-
coated beads are taken up in greater quantities. Only a small number of cells binds or internalize IgM-coated beads. Bead uptake saturates at 100–
500 mg/ml IgG-coating concentrations. Percentage values for each IgG and IgM condition will add up to the corresponding values shown in panel A.
(C) Differential interference contrast (DIC) images show examples of IgG-coated 8.31 mm large beads that associate with or are engulfed by
macrophages. A similar effect was not seen with IgM-, or BSA- or PBS-coated beads. Scale bar is 10 mm.
doi:10.1371/journal.pone.0017223.g002
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indicates that both PBS and BSA control conditions had most of
the cells within the lower fluorescence gate, indicating the
presence of a few beads per cell under these conditions (Fig. 6B).
Conversely, gate B (Fig. 6C) best illustrates the concentration
dependent effect of IgM on enhancing the binding and uptake of
small particles by macrophages. As the IgM concentration
increases the percent of total events counted within that gate
also increases proportionally, indicating that IgM promotes
binding or internalization of relatively larger number of beads
by most of the macrophages. Taken together, these data further
shows that IgM increases the ability for macrophages to
phagocytose micron-sized particles in a concentration-dependent
manner.
IgM binds to small-size late apoptotic cells and
vesicle-like small apoptotic particles
Natural IgM preferentially binds late apoptotic cells [20,22].
Our recent studies show that purified IgM and IgM present in
the normal human serum bind to late apoptotic cells, particularly
to specific regions of the cells [30]. These data illustrated a
general increase in the number of cells to which IgM binds as
cells progressed through to the later stages of apoptosis. During
apoptosis, dying cells can release microparticles similar in size to
the small beads (Figs. 1, 2, 3, 4, 5, 6). Thus, to evaluate a
potential biological relevance for the data presented above, we
examined late apoptotic cells incubated with IgM and probed
the cells with a fluorescent antibody against IgM using
fluorescence microscopy. We found that IgM preferentially
binds well to a subpopulation of the late apoptotic cells that
appear smaller and smoother in relative size and texture
(Figs. 7A–F). The characteristic features suggest that they are
late apoptotic bodies. Additionally, we observed IgM bound to
numerous microparticles (,2 mm) or vesicle-like very small
apoptotic particles (v-SAPs) that were released locally by
apoptotic cells (Figs. 7A–F).
To verify that IgM was binding to these smaller apoptotic cells
and particles, we also performed flow cytometry on these late
apoptotic cells with a low event size cut-off (2 mm or greater;
Fig. 7G). These results indicated that IgM specifically binds to
small size cells. This flow cytometry data would correspond to the
highly labeled small size cells seen by fluorescence microscopy
(Figs. 7A–F). To verify the interaction between IgM and v-SAPs by
flow cytometry, we further reduced the event size cut-off to 0.5 mm
or greater. The data showed that IgM indeed bound to v-SAPs
present in late apoptotic cell preparations (Fig. 7H). In a
representative experiment, gated events from control preparations
with no IgM displayed 0.32% of total events while in preparations
containing 10 mg/ml IgM 8.17% of total events were counted
within the same gate (.25-fold difference). Therefore, taken
together our results indicate that IgM binds to small-sized late
apoptotic cells and v-SAPs.
Figure 3. Human IgM preferentially enhances the binding and
uptake of smaller-sized particles. Macrophages were incubated
with different size beads that are coated with IgM, IgG or PBS. (A) The
percentage of macrophages involved in bead binding and uptake
compared to bead size and bead coating condition. Phagocytic
macrophages are the cells that contained at least one bead. Non-linear
regression analyses between phagocytic microphage (%) and bead
diameter: IgG (y=60.1 x
0.1354;r
2=0.49) and IgM (y=51.6 x
20.815;
r
2=0.94). These two regression lines are different from zero and to each
other (p,0.05). PBS condition does not fit a similar mathematical
equation. (B–E) Phagocytic macrophages shown in (A) were examined
and counted for the number of beads bound and internalized under
varying protein coating conditions and the bead diameter. The
percentages of phagocytic macrophages were plotted separately for
beads with (B) 1.58 mm, (C) 3.87 mm, (D) 5.19 mm and (E) 8.31 mmi n
mean diameter. X-axis is the same for charts B–E: 1–2, one to two; 3–4,
three to four; 5+, 5 or more beads/cell. Note: Only the phagocytic
macrophages are shown in the bar charts; hence, the values for each
condition shown in (B–E) will add up to the corresponding values
shown in (A); *, p,0.05 (Tukey’s test).
doi:10.1371/journal.pone.0017223.g003
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macrophages
The v-SAPs are small biological particles that can quickly be
processed by macrophages. Thus to ascertain v-SAP uptake, we
incubated v-SAPs with the fluorescent beads, allowed IgM or
IgG to bind to these particles and fed them to macrophages.
This method permitted us to measure and compare the effect of
IgM on the internalization of the v-SAP-coated beads. We used
flow cytometry to compare PBS and IgG control conditions
(Fig. 8A) with various concentrations of IgM (10–400 mg/ml;
Fig. 8B). Flow cytometry graphs show that IgM increases in the
uptake of v-SAP-coated beads in a concentration-dependent
manner; moreover, IgG did not generate a notable increase in
clearance compared to the PBS control (Fig. 8A). Thus, our data
suggests that IgM specifically bound vSAP-coated beads and
facilitates their clearance by macrophages.
Discussion
The binding and uptake of particles by macrophages are
essentials functions attributed to these phagocytic cells of the
innate immune system. The clearance of various bioparticles
is a primary responsibility of macrophages [36,37,38,39,40].
Understanding this process is not complete without describing
the parameters that influence particle uptake. In a recent study,
the geometry of target particles has been shown to be critical to the
phagocytic function of macrophages [6]. Here we show that
particle size plays a central role regulating antibody-dependent
clearance of particles (Figs. 1, 2, 3, 4, 5, 6). We compared the
uptake of different sized particles opsonized with IgG or IgM by
macrophages. IgM preferentially enhances the uptake of small
particles (,1 mm). We further identify a biological relevance to our
findings by illustrating that IgM binds to small apoptotic cells and
very small microparticles released from these apoptotic cells
Figure 5. Confocal microscopy images show that macrophages internalize large numbers of human IgG- and IgM-coated beads.
Confocal images show that macrophages internalize only a few BSA- or PBS-coated beads (1 mm); these beads are primarily bind to macrophages. In
contrast, macrophages effectively internalize large numbers of IgG- and IgM-coated beads. Most of these beads are found as 3-D masses within the
macrophages. Top and left strips in each panel show different views (X, Y, Z) of the same cells at a confocal plane. Scale bar is 10 mm.
doi:10.1371/journal.pone.0017223.g005
Figure 4. Epifluorescence microscopy reveals that both human and mouse IgM enhance the binding and uptake of small particles
by macrophages. (A) Mouse macrophages incubated with human IgM-, human IgG-, BSA-, or DPBS-coated 1 mm beads show distinct fluorescence
bead binding or internalization patterns. Left panel shows macrophages and their binding and uptake of beads coated with PBS, BSA (100 mg/ml),
IgG (100 mg/ml) or dissociated IgG (100 mg/ml). Right panel shows the uptake of IgM (0–400 mg/ml) or dissociated IgM (100 mg/ml)-coated beads by
representative macrophages. Coating of beads with increasing concentrations of IgM shows increasing fluorescence in the macrophages.
Dissociating both IgG and IgM eliminates antibody-dependent uptake of these beads by macrophages. Numerical values denote the concentrations
of IgM (mg/ml) used for coating the beads. (B) Macrophages phagocytose mouse IgG (100 mg/ml) and mouse IgM (100 mg/ml)-coated small beads
(1 mm). Both human (A) and mouse (B) antibodies show similar effects. Scale bar is 10 mm.
doi:10.1371/journal.pone.0017223.g004
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coated beads by macrophages (Fig. 8). Our study therefore
describes two novel functions for IgM – (i) antibody-mediated
small particle clearance and (ii) binding to small apoptotic cells and
microparticles, and the clearance of microparticle beads by
macrophages.
Macrophages phagocytose antibody-coated particles that are
more than 1 mm in diameter [35,36]; and to identify the role of
IgM in particle clearance, we used antibody opsonized sheep red
blood cells as a model biological target particle for phagocytosis
(Fig. 1). This is a well-established model of particle uptake that is
commonly used to examine phagocytic events [35,41]. Our data
illustrates that IgG-opsonized sRBCs, but not varying dilutions of
anti-sRBC IgM, are readily engulfed by macrophages within 30
minutes of feeding. Thus, the function of IgM in antibody-
mediated engulfment is likely distinct from that of IgG, and may
have a different biological relevance. Similar experiments using
uniformly sized beads that are similar in size range as the sRBCs
(Fig. 2), again show that IgG, but not IgM, facilitates the
engulfment of these large beads (,8.31 mm) at both low and high
concentrations. Both of these experiments indicate that IgM does
not mediate clearance in the same manner as does IgG.
We then address the effect of particles size on uptake by using
various sized beads ranging from 1.58 mm to 8.31 mm opsonized
with IgG or IgM (Fig. 3). The data illustrates that IgM
opsonization preferentially mediates the clearance of the smaller
particles, whereas IgG opsonization mediates the clearance of
particles of various sizes, showing a positive trend for enhancing
the clearance of larger particles. A previous study suggests that IgG
preferentially enhances the uptake of mid-size (2–3 mm) particles,
but not larger particles [42]. However, the ability of IgG to
enhance the phagocytosis of large beads and sRBCs has been well
established [4,5,35]. Our data (Figs. 1, 2, 3, 4, 5, 6) are consistent
with the fact that IgG internalizes small and large particles.
After identifying various particle sizes and establishing that IgM
opsonization enhances the clearance of the small particles, we
tested a variety of IgM concentrations to more clearly understand
the effects of IgM opsonization on small particle clearance. We
used fluorescent microscopy (Figs. 4, 5) and flow cytometry (Fig. 6)
to evaluate the concentration effect of IgM opsonization on small
particle (1 mm) uptake by macrophages [40,43]. Fluorescent
microscopy enabled us to qualitatively compare the pattern of
small particle uptake caused by IgM opsonization where as
confocal images confirmed that IgM promote the phagocytosis of
these beads. This analysis revealed a concentration dependent
effect, where increased numbers of particles are internalized by
macrophages when the particles are coated with higher concen-
trations of IgM. It is known that human, rabbit and mouse
antibodies can support the uptake of particles by mouse
macrophages [35]; however, we tested species matched antibodies
to confirm the effect of IgM on phagocytosis. Like human IgM,
mouse IgM also enhanced the phagocytosis of small beads, but not
large particles by mouse macrophages (Figs. 1, 4).
After establishing that IgM opsonization enhances small
particle clearance, we considered a biological situation. Recently,
we have identified that IgM can enhance the clearance of
apoptotic cells in the lungs of mice by binding directly to late
apoptotic cells [30]. Moreover, IgM has been implicated
indirectly in apoptotic cell clearance – a direct effect was not
shown [13,21,22,44,45]. This illustrates the importance for
understanding the role IgM plays in particle clearance.
Furthermore, the role played by natural IgM in a variety of
diseases including tissue injury, autoimmunity, cancer and
immune surveillance, has gained considerable interest recently
[17,19,20,46]. Interestingly, IgM binds to small late apoptotic
cells and to vesicle-like small apoptotic particles (Fig. 7), and
enhances the clearance of beads coated with these small apoptotic
particles (Fig. 8). Thus, the IgM-mediated size-restrictive
clearance is likely to functions as a means of achieving apoptotic
cell clearance without promoting inflammation.
Figure 6. Flow cytometry reveals that IgM enhances the
binding and uptake of small particles by macrophages in a
concentration-dependent manner. (A) Overlay comparison (% of
Max) of IgM-coated (10, 100, 200, 400 mg/ml), IgG-coated (100 mg/ml),
BSA-coated (100 mg/ml) or DPBS-suspended beads. IgM conditions are
represented with varying hues of green lines, IgG in a blue line, BSA in
dark red, PBS in bright red, and macrophages alone with a black line.
Gates A and B partition cells containing beads to resolve the population
of cells containing few beads from those with many beads. (B) Gate A
represents the population of cells (% of total events) with few beads as
indicated by lower fluorescent values. (C) Gate B represents the
population of cells (% of total events) with many beads as indicated by
higher fluorescent values.
doi:10.1371/journal.pone.0017223.g006
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IgM-mediated particle clearance, some studies suggest that IgM is
involved in antibody-mediated engulfment of microbes [8,9,12].
Furthermore, use of nanoparticles and microparticle for immune
therapies and vaccines is becoming an important aspect of treating
several diseases [34]; however, the immune molecules that regulate
the clearance and delivery of these antigens have not been clearly
established. The accumulation of immune complexes, dying cells,
apoptotic blebs and microparticles in tissues and organs are root
causes for many autoimmune diseases [32,33,47,48,49]. There-
fore, in addition to determining the roles of other IgM-like innate
immune proteins such as lung surfactant protein D [1,2,43,50,51],
the complete understanding of IgM-mediated apoptotic particle
clearance is essential to effectively treat and control diseases of
biological particle accumulation, autoimmunity (e.g., SLE or
rheumatoid arthritis), infection and inflammation.
Materials and Methods
Ethics statement
All animal work was completed with the approval of the
Research Ethics Board of the Hospital for Sick Children, Toronto,
Ontario, Canada (No: 1000008179).
Animals
Six to twelve week old CD1 mice were purchased from Charles
River Canada (Saint-Constant, Que ´bec) and maintained at the
Laboratory Animal Services (LAS) at the Hospital for Sick
Children, Toronto.
Reagents and buffers
All reagents or antibodies were purchased from Sigma-Aldrich
Canada Ltd. (Oakville, Ontario) unless otherwise stated. Key
antibody reagents used in this study are: Soluble IgM purified
from pooled human plasma. Sigma-Aldrich used selective protein
precipitation and gel filtration techniques for IgM purification.
Identity and purity of the IgM was established by immunoelec-
trophoresis (IEP) and high-pressure liquid chromatography
(HPLC). Electrophoresis of the immunoglobulin preparation
followed by diffusion versus anti-human whole serum resulted in
a single arc of precipitation (product #I8260); FITC-labeled goat-
anti-human IgM (product #F6255); mouse anti-sRBC IgM
(#CL9000-1, Cedarlane); rabbit anti-sRBC IgG (#ICN55806;
ICN/Cappel West Chester, PA, USA); human IgG (#I8640).
Hanks buffered saline solution (HBSS, Gibco) was supplemented
with 3 mM CaCl2 unless otherwise indicated. Cell media used
include RPMI (Wisent) and macrophage serum-free media (M-
SFM) from Gibco (product #12065). Both media were supple-
mented with 10 U/ml penicillin, 10 mg/ml streptomycin and
1 mg/ml of Fungizone (Amphotericin B - all from Gibco).
Generation of apoptotic cells and IgM binding
The human Jurkat T-cells were purchased from ATCC (clone
E6-1 ATCC# TIB-152) and cultured in RMPI media (Wisent)
supplemented with heat inactivated 10% (v/v) FBS (Gibco), 10 U/
ml penicillin and 10 mg/ml streptomycin (Gibco; in complete
culture media) at 37uC with 5% (v/v) CO2. For apoptosis assays,
Jurkat cells were adjusted to a concentration of 1610
6 cells/ml in
2 ml of HBSS. Cells were seeded in 12-well plates on sterile
coverslips. Apoptosis of the cells was induced by 30 seconds of UV-
irradiation (254 nm) with a Stratalinker 2400 crosslinker (Strata-
gene) using the default power settings (120,000 mJ/cm
2). The
buffer was removed and replaced with HBSS buffer (control) or
HBSS with IgM or FITC-labeled human IgM (10 mg/ml) and the
cells were incubated for 24 h at 37uC with 5% CO2.
Fluorescence microscopy
Following the 24 hour incubation (with no IgM controls or
10 mg/ml human IgM), cells were briefly washed and fixed with
2% (v/v) PFA. Cells were then probed with FITC conjugated goat
anti-human IgM antibody (10–20 mg/ml) in the plate wells and
washed. Finally, mounting media containing 49, 6-diamidino-2-
phenylindole (DAPI) was added, incubated and slides were
adhered to a glass microscope slide, dried and examined with an
epifluorescence microscope (Leica, Bannockburn, IL. U.S.A).
Images were created using the OpenLab (Improvision, U.K.).
Figure 8. Flow cytometry shows that human IgM increases the
uptake of fluorescent beads coated with v-SAPs by alveolar
macrophages. Fluorescent beads coated with v-SAPs were incubated
with (A) PBS or IgG (100 mg/ml) or (B) with increasing concentrations of
IgM (10, 100, 200, 400 mg/ml). Macrophage negative control is
represented by the red line in both (A) and (B). In (A), the blue line
r e p r e s e n t sP B Sa n dt h eo r a n g el i n ei sI g G .I n( B ) ,i n c r e a s i n g
concentrations of IgM are represented by the increasing darkness of
the green lines.
doi:10.1371/journal.pone.0017223.g008
Figure 7. Human IgM preferentially binds to a subpopulation of late apoptotic cells and vesicle-like small apoptotic particles (v-
SAPs) or apoptotic ‘‘microparticles’’. (A) Differential interference contrast (DIC) microscopy image. (B) Epifluorescence microscopy image
showing the preferential interaction between IgM (green) and small apoptotic cells (arrow) and microparticles (arrowheads). (C) Fluorescence image
showing that these cells still contain DNA stained blue with DAPI. (D) Overlay of (B) and (C) shows the locations of IgM binding in relation to the
location of the nuclei. (E) Overlay of (A) and (C) shows the locations of nuclei in these cells. (F) Overlay of (A) and (B) shows IgM also binds to larger
cells as small faint punctate dots. Overall, these images show that IgM avidly binds to a subpopulation of relatively smaller cells with smooth regular
surfaces (arrows) and v-SAPs or microparticles (arrowheads). Scale bar is 10 mm. (G–H) Flow cytometry showing that IgM binds small size late
apoptotic cells and microparticles or v-SAPs. (G) Flow cytometry shows that large amounts of IgM can bind to smaller apoptotic cells using a voltage
setting that is sensitive to events measured at 2 mm or greater. (H) Flow cytometry confirming that IgM can bind to v-SAPs using a voltage setting
that is sensitive to events measured at 0.5 mm or greater.
doi:10.1371/journal.pone.0017223.g007
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human IgM antibody) were used for setting the background, in
which no fluorescence signal was detectable. Using the same
setting, experimental slides were imaged.
Flow cytometry
After the induction of apoptotic cells, cells were incubated with
no IgM buffer control or 10 mg/ml human IgM for 24 h in
Eppendorf tubes, washed, suspended in HBBS and probed with a
FITC conjugated goat anti-human IgM antibody (10–20 mg/ml;
pre-centrifuged at 10,000 6g; 0.22 mm filter). Cells in suspension
were fixed in 1–2% (v/v) PFA. Fluorescence intensities of cells
were acquired with a FACScan flow cytometer (Becton Dickinson,
Mississauga ON). Voltages were adjusted for sensitivity to particles
greater than or equal to 2 mm or 0.5 mm. Data was analyzed with
Flowjo (Tree Star Inc., Ashland OR. U.S.A.). See bead uptake
section for additional flow cytometry information.
Alveolar macrophage cell culture
Alveolar macrophages were obtained by bronchoalveolar lavage
(BAL) of mice as previously described [40]. Briefly, mice were
sacrificed and their abdominal cavities were opened, and
exsanguinated, revealing the lungs. The lungs were cyclically
inflated and deflated 3 times with 1 ml of DPBS (Gibco) using a
1 ml syringe and a BD Angiocath (BD Bioscience) inserted into the
exposed trachea. This was repeated 5 times for a total lavage fluid
volume of 5 ml. Lavage fluid from 2 or more mice was pooled and
kept on ice until centrifugation for 20 min at 4006ga t4 uC. Cell
pellets were treated with sterile water for 10 seconds to lyse
residual erythrocytes followed by a 1:9 dilution of the water with
M-SFM cell culture media. The cells were seeded equally into
chambers of 8-well chamber slides (BD Falcon, REF# 354118)
and macrophages were allowed to adhere to the glass slides for a
minimum of 30 minutes at 37uC. Cells were then washed with
sterile DPBS and incubated further in M-SFM for up to 4 h then
used for uptake experiments. For confocal microscopy experi-
ments, macrophages were labeled with PKH 26 dye (Sigma).
sRBC phagocytosis
To coat the sheep red blood cells with antibody, 200 ml of cells
per condition were centrifuged for 10 s at 20006g. The cells were
washed in 1 ml of DPBS and pelleted again with a 10 s
centrifugation. The washed pellets were resuspended in DPBS
containing mouse anti-sheep erythrocyte IgM at the necessary
dilution (1/50, 1/100, 1/200, 1/400, or 1/800), rabbit anti-sheep
erythrocyte IgG (1/50) or buffer alone. The sRBCs were
incubated in a Thermomixer R (Eppendorf) for 2 h at 37uC with
continuous shaking at 900 RPM. Following incubation, sRBCs
were washed 2–3 times with DPBS and resuspended in M-SFM.
From this, 100 ml of sRBCs was introduced to each wells of an 8-
well chamber slide already containing adherent macrophages
obtained and cultured as described above. One well remained free
of sRBCs to serve as double negative control. The cells were co-
incubated for 30 min at 37uC with 5% (v/v) CO2. Following this
incubation slides were placed on ice for 10 minutes to stop
phagocytosis. Chambers were carefully washed by the addition
and removal of 200 ml of DPBS. Residual sRBCs were lysed with
the addition of 200 ml of sterile water for 30 s. Following sRBCs
lysis, solution in each well was replaced with 200 ml of DPBS to
maintain the vitality of the cells while immediately viewing and
photographing the live cells with a light microscope and a digital
camera. The sRBC phagocytic index represents the number of
sRBC internalized per 100 macrophages. The values are expressed
as the mean ratio 6 SEM for an n=3.
Bead uptake
Yellow-green fluorescent or colourless beads (Polysciences,
Inc., Warrington PA, USA; and Bangs Laboratories, Fishers, IN,
USA), ranging in sizes from 1 to 8.31 mmi nm e a nd i a m e t e r ,
were suspended in DPBS then briefly sonicated to generate a
uniform suspension of single beads as previously described
[40,43]. Beads for each size and condition were centrifuged to
pellet with a tabletop microcentrifuge. Beads were incubated in
50 ml of human IgM or IgG (10, 100, 200, 400 mg/ml), BSA
(100 mg/ml), or DPBS for 75–90 minutes at 37uCo na
Thermomixer R (Eppendorf) shaking at 900 RPM. In some
experiments, 100 mg/ml IgG and IgM were incubated at 37uC
for 30 min in the presence of 50 mM dithiothreitol (DTT) then
boiled for 30 min in the same buffer and cooled back to 37uC
before using them for coating the beads. Following this
incubation, beads were centrifuged as previously described and
washed 1–2 times with 50 ml of DPBS. Protein-coated and
control beads were resuspended into 100 ml of M-SFM. The
beads were added to macrophages obtained and seeded into the
wells of 8-well chamber slides as described above. The slides
were centrifuged on a swinging-arm plate rotor at 1006gf o r
2 min to ensure beads made contact with macrophages in a
time-synchronized manner. The slides with beads and cells were
incubated for 30 min at 37uCw i t h5 %C O 2 (v/v) in M-SFM.
Following incubation, media was removed and cells were washed
extensively 2–3 times with sterile DPBS. We have also tested the
assay using RPMI supplemented with heat inactivated 10% (v/v)
FCS instead of M-SFM. Both of these media showed similar
IgM-mediated binding and uptake of small particles (data not
shown). However, we used M-SFM to eliminate any potential
confounding effects exerted by the antibodies present in the heat
inactivated FCS.
For flow cytometry experiments, cells were treated with
Accutase and/or Trypsin (Sigma) to reduce adherence for 10–
20 min at 37uC+5% CO2 (v/v). Cells were then scraped off the
glass slide surface with a micropipette tip. Cells were immediately
added to 4% (v/v) PFA for fixation and incubated overnight at
4uC in the dark. Cells were pelleted and resuspended in DPBS and
analyzed with a BD FACS ARIA-II. Cells examined by
fluorescence or light microscopy (Leica, Bannockburn, IL.
U.S.A) were fixed with 4% (v/v) PFA immediately after through
DPBS washes and overnight storage at 4uC in the dark. Slides
were mounted with Dako fluorescent mounting media and a glass
coverslip and allowed to dry overnight. Images were processed
using the OpenLab or Volocity (both from Improvision, U.K.).
For each condition, macrophages were counted for 2–5 replicate
experiments (100–500 cells/condition, and at least 50 cells for
negative controls). These slides were also examined with a
spinning disc confocal microscope (Carl Zeiss Canada, Toronto)
and analyzed in three dimensions using Z-stack imaging Volocity
(Improvision, U.K.).
For some experiments, 24 h apoptotic cell suspensions were
centrifuged for 10 min at 4006g. The supernatant was removed
and recentrifuged at a high speed (25,0006g for 20 min) to pellet
microparticles. These microparticles were allowed to coat 1 mm
green fluorescent beads in a shaker for 2 h, washed (10 min at
4006g) and further incubated with different concentrations of IgM
(10, 100, 200, 400 mg/ml), IgG (100 mg/ml) or Tris buffer for 60–
90 minutes at 37uC, followed by a 20–30 incubation on ice.
Unbound proteins were removed by washes (10 min at 400 6g),
and the beads were incubated with alveolar macrophages in M-
SFM for 30 min at 37uC. The cells were processed for flow
cytometry as described above.
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Where statistical analysis was deemed appropriate to evaluate
differences amongst conditions or their respective controls, an
ANOVA was used for multiple means comparison with a Tukey’s
HSD correction or a Dunnett’s control comparison test (where
necessary) using the JMP statistical package (SAS, North
Carolina). Statistically significant data are noted by asterisks
(*, p,0.05). To compare line functions, regression analysis was
performed using the JMP or the Prism statistical package
(GraphPad, San Diego, California). All data presented in this
paper is representative of 2–5 replicate experiments and figures
were organized using Microsoft Excel and Adobe Illustrator.
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